Medicare Enrolled

Dr. Adrian Bersabe, M.D.

Hematology & Oncology · Pensacola, FL
1545 AIRPORT BLVD STE 2000, Pensacola, FL 32504
8504166933
Registered in NPPES since 2011
NPI: 1336432756 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bersabe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bersabe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bersabe

Dr. Adrian Bersabe is a hematology & oncology specialist in Pensacola, FL, with 15 years of NPI registration.

Between the years covered by Open Payments, Dr. Bersabe received a total of $3,549 from 42 pharmaceutical and/or device companies across 117 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bersabe is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years of NPI registration $3,549 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 173642 Clear January 31, 2027 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$3,549
Total received (2018-2024)
Avg $507/year across 7 years
Bottom 46% in FL for hematology & oncology
42
Companies
117
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$687
2023
$883
2022
$306
2021
$448
2020
$426
2019
$575
2018
$223

Payments by company (2024)

Stemline Therapeutics Inc.
$124
Merck Sharp & Dohme LLC
$80
Dendreon Pharmaceuticals LLC
$65
Gilead Sciences, Inc.
$62
Regeneron Healthcare Solutions, Inc.
$52
Astellas Pharma US Inc
$50
Celgene Corporation
$39
Daiichi Sankyo Inc.
$34
PROGENICS PHARMACEUTICALS, INC.
$27
GlaxoSmithKline, LLC.
$22
Eisai Inc.
$22
AstraZeneca Pharmaceuticals LP
$21
E.R. Squibb & Sons, L.L.C.
$20
Rigel Pharmaceuticals, Inc.
$19
Ipsen Biopharmaceuticals, Inc
$16
SOBI, INC
$16
Aveo Pharmaceuticals, Inc.
$16
Top 3 companies account for 39.1% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$361
SANOFI-AVENTIS U.S. LLC
$347
GENZYME CORPORATION
$302
Ipsen Biopharmaceuticals, Inc
$259
Regeneron Healthcare Solutions, Inc.
$234
Daiichi Sankyo Inc.
$180
Merck Sharp & Dohme LLC
$176
BeiGene USA, Inc.
$162
Stemline Therapeutics Inc.
$157
EMD Serono, Inc.
$154
E.R. Squibb & Sons, L.L.C.
$114
AbbVie Inc.
$90
AstraZeneca Pharmaceuticals LP
$75
AbbVie, Inc.
$66
Dendreon Pharmaceuticals LLC
$65
Gilead Sciences, Inc.
$62
GlaxoSmithKline, LLC.
$59
Genentech USA, Inc.
$55
Astellas Pharma US Inc
$50
Incyte Corporation
$49
Puma Biotechnology, Inc.
$44
EAGLE PHARMACEUTICALS, INC.
$43
ADC Therapeutics America, Inc.
$41
Celgene Corporation
$39
G1 Therapeutics, Inc.
$32
AMAG Pharmaceuticals, Inc.
$31
PROGENICS PHARMACEUTICALS, INC.
$27
Seattle Genetics, Inc.
$25
Janssen Pharmaceuticals, Inc
$24
PFIZER INC.
$22
Eisai Inc.
$22
TAIHO ONCOLOGY, INC.
$21
MorphoSys, US Inc.
$20
Rigel Pharmaceuticals, Inc.
$19
Blueprint Medicines Corporation
$18
Seagen Inc.
$18
AVEO Pharmaceuticals, Inc.
$18
SOBI, INC
$16
Aveo Pharmaceuticals, Inc.
$16
Amgen Inc.
$13
Helsinn Therapeutics (U.S.), Inc.
$13
Relypsa, Inc.
$12
Top 3 companies account for 28.5% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKYNZEO · AYVAKIT · Alecensa · BARHEMSYS · BAVENCIO · BLENREP · BRUKINSA · BYFAVO · CALQUENCE · COSELA · DOPTELET · ENHERTU · Enhertu · FERAHEME · FOTIVDA · INJECTAFER · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · LIBTAYO · LONSURF · Lenvima · MONJUVI · NERLYNX · OPDIVO · Onivyde · Orserdu · PADCEV · PROVENGE · PYLARIFY · REBLOZYL · Repatha · Rezlidhia · SOMATULINE DEPOT · TAGRISSO · TECENTRIQ · TEZSPIRE · VENCLEXTA · Veltassa · Venclexta · XARELTO · Xospata · Xtandi · ZAVZPRET
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Pensacola?
Compare hematology & oncology specialists in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
20
County median income
$65,715
Nearest hospital to ZIP centroid (approximate)
SACRED HEART HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bersabe is a hematology & oncology specialist, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Bersabe receive payments from pharmaceutical companies?
Yes. Dr. Bersabe received a total of $3,549 from 42 companies across 117 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Bersabe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in Pensacola
Browse hematology & oncology specialists in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →